Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro

BACKGROUND: The peroxisome proliferator-activated receptor-γ (PPARγ) agonist rosiglitazone has been suggested to exert cardiovascular protection through the improvement of lipid metabolism, anti-inflammation, anti-proliferation etc. However, whether renin-angiotensin system (RAS) is involved in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Liqun, Liu, Naifeng, Zhi, Hong, Li, Yingjuan, Li, Yanzhi, Tang, Rining, Sheng, Zulong
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039565/
https://www.ncbi.nlm.nih.gov/pubmed/21269478
http://dx.doi.org/10.1186/1475-2840-10-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039565/
https://www.ncbi.nlm.nih.gov/pubmed/21269478
http://dx.doi.org/10.1186/1475-2840-10-10

Ejemplares similares